• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转甲状腺素蛋白家族性淀粉样多发性神经病(TTR-FAP):早期诊断的参数。

Transthyretin familial amyloid polyneuropathy (TTR-FAP): Parameters for early diagnosis.

机构信息

Department of Neurology University Medical Center of the Johannes Gutenberg University Mainz Mainz Germany.

German Association for Liver Transplantation Mainz Germany.

出版信息

Brain Behav. 2017 Dec 19;8(1):e00889. doi: 10.1002/brb3.889. eCollection 2018 Jan.

DOI:10.1002/brb3.889
PMID:29568686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5853640/
Abstract

BACKGROUND

Familial transthyretin amyloidosis is a life-threatening disease presenting with sensorimotor and autonomic polyneuropathy. Delayed diagnosis has a detrimental effect on treatment and prognosis. To facilitate diagnosis, we analyzed data patterns of patients with transthyretin familial amyloid polyneuropathy (TTR-FAP) and compared them to polyneuropathies of different etiology for clinical and electrophysiological discriminators.

METHODS

Twenty-four patients with TTR-FAP and 48 patients with diabetic polyneuropathy (dPNP) were investigated (neurological impairment score NIS; neurological disability score NDS) in a cross-sectional design. Both groups were matched for gender and presence of pain. Quantitative sensory testing (QST), sympathetic skin response (SSR), heart rate variability (HRV), and nerve conduction studies (NCV) were performed. Both groups were compared using univariate analysis. In a stepwise discriminant analysis, discriminators between both neuropathies were identified. These discriminators were validated comparing TTR-FAP patients with a cohort of patients with chemotherapy-induced polyneuropathy (CIN) and chronic inflammatory demyelinating neuropathy (CIDP).

RESULTS

TTR-FAP patients scored higher in NDS and NIS and had impaired cold detection (CDT,  = .024), cold-warm discrimination (TSL,  = .019) and mechanical hyperalgesia (MPT,  = .029) at the hands, SSR (upper limb,  = .022) HRV and ulnar and sural NCS (all  < .05) were more affected in TTR-FAP. Ulnar nerve sensory NCV, CDT, and the MPT but not the other parameters discriminated TTR-FAP from dPNP (82% of cases), from CIN (86.7%) and from CIDP (68%; only ulnar sNCV).

CONCLUSION

Low ulnar SNCV, impaired cold perception, and mechanical hyperalgesia at the hands seem to characterize TTR-FAP and might help to differentiate from other polyneuropathies.

摘要

背景

家族性转甲状腺素蛋白淀粉样变性是一种危及生命的疾病,表现为感觉运动和自主多发性神经病。延迟诊断对治疗和预后有不利影响。为了便于诊断,我们分析了转甲状腺素蛋白家族性淀粉样多神经病(TTR-FAP)患者的数据模式,并将其与不同病因的多发性神经病进行比较,以确定临床和电生理鉴别诊断。

方法

在横断面设计中,对 24 例 TTR-FAP 患者和 48 例糖尿病性多发性神经病(dPNP)患者进行了调查(神经损伤评分 NIS;神经功能障碍评分 NDS)。两组患者的性别和疼痛存在情况相匹配。进行了定量感觉测试(QST)、交感皮肤反应(SSR)、心率变异性(HRV)和神经传导研究(NCV)。使用单变量分析比较两组。在逐步判别分析中,确定了两种神经病之间的鉴别因素。通过比较 TTR-FAP 患者与化疗诱导的多发性神经病(CIN)和慢性炎症性脱髓鞘性神经病(CIDP)患者的队列,验证了这些鉴别因素。

结果

TTR-FAP 患者的 NDS 和 NIS 评分较高,手部冷觉检测(CDT,  = 0.024)、冷温觉辨别(TSL,  = 0.019)和机械性痛觉过敏(MPT,  = 0.029)受损,SSR(上肢,  = 0.022)、HRV 和尺神经和腓肠神经的 NCV(均  < 0.05)在 TTR-FAP 中受影响更严重。尺神经感觉 NCV、CDT 和 MPT 但不是其他参数可将 TTR-FAP 与 dPNP(82%的病例)、CIN(86.7%)和 CIDP(68%;仅尺神经 sNCV)区分开来。

结论

低尺神经 SNCV、手部冷觉感知受损和机械性痛觉过敏似乎是 TTR-FAP 的特征,可能有助于与其他多发性神经病区分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a2f/5853640/cbfc2f5c7321/BRB3-8-e00889-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a2f/5853640/d29f71ce6fc3/BRB3-8-e00889-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a2f/5853640/cbfc2f5c7321/BRB3-8-e00889-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a2f/5853640/d29f71ce6fc3/BRB3-8-e00889-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a2f/5853640/cbfc2f5c7321/BRB3-8-e00889-g002.jpg

相似文献

1
Transthyretin familial amyloid polyneuropathy (TTR-FAP): Parameters for early diagnosis.转甲状腺素蛋白家族性淀粉样多发性神经病(TTR-FAP):早期诊断的参数。
Brain Behav. 2017 Dec 19;8(1):e00889. doi: 10.1002/brb3.889. eCollection 2018 Jan.
2
Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy.定量出汗测试有助于区分转甲状腺素蛋白家族性淀粉样多发性神经病与慢性炎症性脱髓鞘性多发性神经病。
Clin Neurophysiol. 2020 May;131(5):1129-1133. doi: 10.1016/j.clinph.2020.01.022. Epub 2020 Feb 21.
3
Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy.转甲状腺素淀粉样变性多发性神经病,类似于脱髓鞘性多发性神经病。
Neurology. 2018 Jul 10;91(2):e143-e152. doi: 10.1212/WNL.0000000000005777. Epub 2018 Jun 15.
4
Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trials.对转甲状腺素蛋白淀粉样变多发性神经病队列进行回顾性研究,以修改NIS+7用于治疗试验。
J Neurol Sci. 2014 Sep 15;344(1-2):121-8. doi: 10.1016/j.jns.2014.06.041. Epub 2014 Jun 27.
5
Nerve Ultrasound Comparison Between Transthyretin Familial Amyloid Polyneuropathy and Chronic Inflammatory Demyelinating Polyneuropathy.转甲状腺素蛋白家族性淀粉样多神经病与慢性炎症性脱髓鞘性多发性神经病的神经超声比较
Front Neurol. 2021 Feb 26;12:632096. doi: 10.3389/fneur.2021.632096. eCollection 2021.
6
The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy.Sudoscan在转甲状腺素蛋白家族性淀粉样多神经病中的诊断准确性。
Clin Neurophysiol. 2016 May;127(5):2222-7. doi: 10.1016/j.clinph.2016.02.013. Epub 2016 Feb 27.
7
Assessment of autonomic innervation of the foot in familial amyloid polyneuropathy.家族性淀粉样多神经病患者足部自主神经支配评估。
Eur J Neurol. 2019 Jan;26(1):94-e10. doi: 10.1111/ene.13774. Epub 2018 Sep 12.
8
"Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathy.转甲状腺素蛋白家族性淀粉样多神经病中的“红旗”症状群
J Peripher Nerv Syst. 2016 Mar;21(1):5-9. doi: 10.1111/jns.12153.
9
Follow-up in transthyretin familial amyloid polyneuropathy: Useful investigations.转甲状腺素蛋白家族性淀粉样多神经病的随访:有用的检查
J Neurol Sci. 2020 Jun 15;413:116776. doi: 10.1016/j.jns.2020.116776. Epub 2020 Mar 18.
10
Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort.载脂蛋白 A97 丝氨酸转甲状腺素蛋白淀粉样变性相关性多发性神经病:泰国队列的临床和神经生理学特征。
BMC Neurol. 2021 May 22;21(1):206. doi: 10.1186/s12883-021-02243-3.

引用本文的文献

1
A new screening tool for early recognition of ATTRv polyneuropathy in clinical practice: AmyloScan.一种用于临床实践中早期识别转甲状腺素蛋白淀粉样变性多神经病的新型筛查工具:淀粉样蛋白扫描。
J Neurol. 2025 Sep 4;272(9):608. doi: 10.1007/s00415-025-13338-z.
2
Advances in the treatment of transthyretin amyloidosis.转甲状腺素蛋白淀粉样变性病的治疗进展
eGastroenterology. 2025 Jul 18;3(3):e100198. doi: 10.1136/egastro-2025-100198. eCollection 2025.
3
Clinical Cues for the Early Diagnosis of Transthyretin-Related Polyneuropathy.转甲状腺素蛋白相关多神经病早期诊断的临床线索

本文引用的文献

1
MRI of pathology-proven peripheral nerve amyloidosis.经病理证实的周围神经淀粉样变性的磁共振成像
Skeletal Radiol. 2017 Jan;46(1):65-73. doi: 10.1007/s00256-016-2510-8. Epub 2016 Oct 12.
2
Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses.遗传性和炎症性神经病:对已报道的相关疾病、类似疾病和误诊的综述。
J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1051-60. doi: 10.1136/jnnp-2015-310835. Epub 2016 Mar 23.
3
First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy.
J Clin Neurol. 2024 Nov;20(6):610-616. doi: 10.3988/jcn.2024.0246.
4
Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal.遗传性转甲状腺素蛋白淀粉样变性症管理的最佳实践:来自日本、巴西和葡萄牙的真实世界经验。
Orphanet J Rare Dis. 2023 Oct 12;18(1):323. doi: 10.1186/s13023-023-02910-3.
5
When cooling of the skin is perceived as warmth: Enhanced paradoxical heat sensation by pre-cooling of the skin in healthy individuals.当皮肤冷却被感知为温暖时:健康个体中皮肤预冷增强的矛盾热感觉
Temperature (Austin). 2022 Jul 22;10(2):248-263. doi: 10.1080/23328940.2022.2088028. eCollection 2023.
6
Quantitative thermal testing as a screening and follow-up tool for diabetic sensorimotor polyneuropathy in patients with type 2 diabetes and prediabetes.定量热测试作为2型糖尿病和糖尿病前期患者糖尿病感觉运动性多发性神经病变的筛查及随访工具。
Front Neurosci. 2023 Mar 27;17:1115242. doi: 10.3389/fnins.2023.1115242. eCollection 2023.
7
Gait Characterization and Analysis of Hereditary Amyloidosis Associated with Transthyretin Patients: A Case Series.遗传性转甲状腺素蛋白相关淀粉样变性患者的步态特征与分析:病例系列
J Clin Med. 2022 Jul 7;11(14):3967. doi: 10.3390/jcm11143967.
8
Motor Conduction Studies and Handgrip in Hereditary TTR Amyloidosis: Simple Tools to Evaluate the Upper Limbs.遗传性转甲状腺素蛋白淀粉样变性的运动传导研究与握力:评估上肢的简单工具
Front Neurol. 2022 Feb 28;13:835812. doi: 10.3389/fneur.2022.835812. eCollection 2022.
9
Unusual Pain Disorders - What Can Be Learned from Them?罕见疼痛障碍——我们能从中学到什么?
J Pain Res. 2021 Mar 15;13:3539-3554. doi: 10.2147/JPR.S287603. eCollection 2020.
10
Clinical 3-D Gait Assessment of Patients With Polyneuropathy Associated With Hereditary Transthyretin Amyloidosis.遗传性转甲状腺素蛋白淀粉样变性相关多神经病患者的临床三维步态评估
Front Neurol. 2020 Nov 23;11:605282. doi: 10.3389/fneur.2020.605282. eCollection 2020.
转甲状腺素蛋白家族性淀粉样多神经病诊断、管理及治疗的首个欧洲共识
Curr Opin Neurol. 2016 Feb;29 Suppl 1(Suppl 1):S14-26. doi: 10.1097/WCO.0000000000000289.
4
Rapid progression of familial amyloidotic polyneuropathy: a multinational natural history study.家族性淀粉样多神经病的快速进展:一项多国自然史研究。
Neurology. 2015 Aug 25;85(8):675-82. doi: 10.1212/WNL.0000000000001870. Epub 2015 Jul 24.
5
Incidence of polyneuropathy in Utrecht, the Netherlands.荷兰乌得勒支多发性神经病的发病率。
Neurology. 2015 Jan 20;84(3):259-64. doi: 10.1212/WNL.0000000000001160. Epub 2014 Dec 12.
6
Recurrence analysis of the EEG during sleep accurately identifies subjects with mental health symptoms.睡眠期间 EEG 的复发分析能准确识别有心理健康症状的受试者。
Psychiatry Res. 2014 Dec 30;224(3):335-40. doi: 10.1016/j.pscychresns.2014.10.004. Epub 2014 Oct 14.
7
Recent advances in transthyretin amyloidosis therapy.近年来转甲状腺素蛋白淀粉样变性病治疗的进展。
Transl Neurodegener. 2014 Sep 13;3:19. doi: 10.1186/2047-9158-3-19. eCollection 2014.
8
Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy.转甲状腺素蛋白家族性淀粉样多神经病诊断与管理的最新进展
J Neurol. 2014 Jun;261(6):1227-33. doi: 10.1007/s00415-014-7373-0. Epub 2014 Jun 3.
9
Pain in chemotherapy-induced neuropathy--more than neuropathic?化疗诱导性神经病中的疼痛——不仅仅是神经病理性疼痛?
Pain. 2013 Dec;154(12):2877-2887. doi: 10.1016/j.pain.2013.08.028. Epub 2013 Aug 30.
10
Guideline of transthyretin-related hereditary amyloidosis for clinicians.转甲状腺素相关遗传性淀粉样变性的临床医生指南。
Orphanet J Rare Dis. 2013 Feb 20;8:31. doi: 10.1186/1750-1172-8-31.